<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-AD01-24CE4Z</udiDi>
    <basicUdiDi>B-AD01-24CE4Z</basicUdiDi>
    <tradeName>IColocomf</tradeName>
    <deviceName>Stool DNA Methylation Detection Kit for Colorectal Cancer (Real-Time PCR)</deviceName>
    <manufacturerName>Wuhan Ammunition Life-tech Co.,Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000037251</manufacturerSrn>
    <authorisedRepresentativeName>Kingsmead Service B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002066</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060214</emdnCode>
    <emdnDescription>COLORECTAL CANCER (MSI-H / DMMR)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AD01-24CE</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:28:17.800Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-A030CQ</udiDi>
    <basicUdiDi>B-A030CQ</basicUdiDi>
    <tradeName>INDICAID™ Breast Cancer Mutation Gene Test (Blood, Gene sequencing technology)</tradeName>
    <deviceName>INDICAID™ Breast Cancer Mutation Gene Test (Blood, Gene sequencing technology)</deviceName>
    <manufacturerName>Phase Scientific International Limited</manufacturerName>
    <manufacturerSrn>HK-MF-000025791</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>INDICAID™ Breast Cancer Mutation Gene Test (Blood, Gene sequencing technology)</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:15:10.574Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-A029D7</udiDi>
    <basicUdiDi>B-A029D7</basicUdiDi>
    <tradeName>INDICAID™ Breast Cancer Mutation Gene Test (Urine, Gene sequencing technology)</tradeName>
    <deviceName>INDICAID™ Breast Cancer Mutation Gene Test (Urine, Gene sequencing technology)</deviceName>
    <manufacturerName>Phase Scientific International Limited</manufacturerName>
    <manufacturerSrn>HK-MF-000025791</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>INDICAID™ Breast Cancer Mutation Gene Test (Urine, Gene sequencing technology)</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:15:09.787Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-A028D5</udiDi>
    <basicUdiDi>B-A028D5</basicUdiDi>
    <tradeName>INDICAID™ Bladder Cancer Mutation Gene Test (Urine, Gene sequencing technology)</tradeName>
    <deviceName>INDICAID™ Bladder Cancer Mutation Gene Test (Urine, Gene sequencing technology)</deviceName>
    <manufacturerName>Phase Scientific International Limited</manufacturerName>
    <manufacturerSrn>HK-MF-000025791</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060215</emdnCode>
    <emdnDescription>BLADDER CANCER DETECTION / MONITORING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>INDICAID™ Bladder Cancer Mutation Gene Test (Urine, Gene sequencing technology)</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:14:42.293Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-A027D3</udiDi>
    <basicUdiDi>B-A027D3</basicUdiDi>
    <tradeName>INDICAID™ Bladder Cancer Methylation Test (Urine, Gene sequencing technology)</tradeName>
    <deviceName>INDICAID™ Bladder Cancer Methylation Test (Urine, Gene sequencing technology)</deviceName>
    <manufacturerName>Phase Scientific International Limited</manufacturerName>
    <manufacturerSrn>HK-MF-000025791</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060215</emdnCode>
    <emdnDescription>BLADDER CANCER DETECTION / MONITORING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>INDICAID™ Bladder Cancer Methylation Test (Urine, Gene sequencing technology)</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:14:41.446Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-A026CZ</udiDi>
    <basicUdiDi>B-A026CZ</basicUdiDi>
    <tradeName>INDICAID™ Bladder Cancer Methylation Test (Urine, PCR-fluorescence probe method)</tradeName>
    <deviceName>INDICAID™ Bladder Cancer Methylation Test (Urine, PCR-fluorescence probe method)</deviceName>
    <manufacturerName>Phase Scientific International Limited</manufacturerName>
    <manufacturerSrn>HK-MF-000025791</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060215</emdnCode>
    <emdnDescription>BLADDER CANCER DETECTION / MONITORING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>INDICAID™ Bladder Cancer Methylation Test (Urine, PCR-fluorescence probe method)</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:14:37.548Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-A025CX</udiDi>
    <basicUdiDi>B-A025CX</basicUdiDi>
    <tradeName>INDICAID™ Cervical Cancer Mutation Gene Test (Urine, Gene sequencing technology)</tradeName>
    <deviceName>INDICAID™ Cervical Cancer Mutation Gene Test (Urine, Gene sequencing technology)</deviceName>
    <manufacturerName>Phase Scientific International Limited</manufacturerName>
    <manufacturerSrn>HK-MF-000025791</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>INDICAID™ Cervical Cancer Mutation Gene Test (Urine, Gene sequencing technology)</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:14:36.643Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-A024CV</udiDi>
    <basicUdiDi>B-A024CV</basicUdiDi>
    <tradeName>NDICAID™ Cervical Cancer Methylation Test (Urine, PCR-fluorescence probe method)</tradeName>
    <deviceName>NDICAID™ Cervical Cancer Methylation Test (Urine, PCR-fluorescence probe method)</deviceName>
    <manufacturerName>Phase Scientific International Limited</manufacturerName>
    <manufacturerSrn>HK-MF-000025791</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NDICAID™ Cervical Cancer Methylation Test (Urine, PCR-fluorescence probe method)</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:14:35.922Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-A023CT</udiDi>
    <basicUdiDi>B-A023CT</basicUdiDi>
    <tradeName>INDICAID™ Cervical Cancer Methylation Test (vaginal or cervical swab, gene sequencing technology)</tradeName>
    <deviceName>INDICAID™ Cervical Cancer Methylation Test (vaginal or cervical swab, gene sequencing technology)</deviceName>
    <manufacturerName>Phase Scientific International Limited</manufacturerName>
    <manufacturerSrn>HK-MF-000025791</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>INDICAID™ Cervical Cancer Methylation Test (vaginal or cervical swab, gene sequencing technology)</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:14:35.048Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-A022CR</udiDi>
    <basicUdiDi>B-A022CR</basicUdiDi>
    <tradeName>INDICAID™ Cervical Cancer Methylation Test (vaginal or cervical swab, PCR-fluorescent probe method)</tradeName>
    <deviceName>INDICAID™ Cervical Cancer Methylation Test (vaginal or cervical swab, PCR-fluorescent probe method)</deviceName>
    <manufacturerName>Phase Scientific International Limited</manufacturerName>
    <manufacturerSrn>HK-MF-000025791</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>INDICAID™ Cervical Cancer Methylation Test (vaginal or cervical swab, PCR-fluorescent probe method)</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:14:31.042Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-9020B4</udiDi>
    <basicUdiDi>B-9020B4</basicUdiDi>
    <tradeName>D-9020B4</tradeName>
    <deviceName>Tumour Protein p53 gene (TP53) Library Prep Kit for Illumina®</deviceName>
    <manufacturerName>NimaGen BV</manufacturerName>
    <manufacturerSrn>NL-MF-000022926</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060201</emdnCode>
    <emdnDescription>P53</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>RC-TP53096-I</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-12T17:55:02.114Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-9019BK</udiDi>
    <basicUdiDi>B-9019BK</basicUdiDi>
    <tradeName>D-9019BK</tradeName>
    <deviceName>Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Library Prep Kit for Illumina®</deviceName>
    <manufacturerName>NimaGen BV</manufacturerName>
    <manufacturerSrn>NL-MF-000022926</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060203</emdnCode>
    <emdnDescription>BRCA 1+2</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>RC-BRCA096-I</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-12T17:54:59.713Z</lastUpdated>
  </row>
  <row>
    <udiDi>8681957090034DQ</udiDi>
    <basicUdiDi>B-8681957090034DQ</basicUdiDi>
    <tradeName>MULTIGEN</tradeName>
    <deviceName>Yeni Nesil Dizi Analizi ile BRCA1 ve BRCA2 Mutasyonlarını Saptama Kiti</deviceName>
    <manufacturerName>MULTİGEN SAĞLIK HİZ. TİC. LTD. ŞTİ.</manufacturerName>
    <manufacturerSrn>TR-MF-000050129</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060203</emdnCode>
    <emdnDescription>BRCA 1+2</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>M-BR-01</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-12T12:41:53.353Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-8437025247GEUSLBC7</udiDi>
    <basicUdiDi>B-8437025247GEUSLBC7</basicUdiDi>
    <tradeName>GEUS-LB®</tradeName>
    <deviceName>GEUS-LB</deviceName>
    <manufacturerName>ANILING SL</manufacturerName>
    <manufacturerSrn>ES-MF-000025687</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GEUS-LB®</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T07:16:06.066Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-8437025247GEUSCRCPD</udiDi>
    <basicUdiDi>B-8437025247GEUSCRCPD</basicUdiDi>
    <tradeName>GEUS-CRC®</tradeName>
    <deviceName>GEUS-CRC</deviceName>
    <manufacturerName>ANILING SL</manufacturerName>
    <manufacturerSrn>ES-MF-000025687</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GEUS-CRC®</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T07:16:03.558Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-8437025247GEUS5Q</udiDi>
    <basicUdiDi>B-8437025247GEUS5Q</basicUdiDi>
    <tradeName>GEUS-CLL®</tradeName>
    <deviceName>GEUS-CLL</deviceName>
    <manufacturerName>ANILING SL</manufacturerName>
    <manufacturerSrn>ES-MF-000025687</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GEUS-CLL®</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-12T07:16:01.156Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-81649002AKRAS01JF42</udiDi>
    <basicUdiDi>B-81649002AKRAS01JF42</basicUdiDi>
    <tradeName>D-81649002AKRAS01JF42</tradeName>
    <deviceName>KRAS Gene Mutation Detection Kit（Fluorescence PCR）</deviceName>
    <manufacturerName>Healgen Scientific Limited Liability Company</manufacturerName>
    <manufacturerSrn>US-MF-000018839</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060202</emdnCode>
    <emdnDescription>K-RAS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AKRAS01-AHG24E</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-12T07:00:22.342Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-81649002AEGFR01D6SQ</udiDi>
    <basicUdiDi>B-81649002AEGFR01D6SQ</basicUdiDi>
    <tradeName>D-81649002AEGFR01D6SQ</tradeName>
    <deviceName>EGFR Gene Mutation Detection Kit（Fluorescence PCR）</deviceName>
    <manufacturerName>Healgen Scientific Limited Liability Company</manufacturerName>
    <manufacturerSrn>US-MF-000018839</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AEGFR01-AHG24E</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-12T06:59:37.478Z</lastUpdated>
  </row>
  <row>
    <udiDi>10190302017305</udiDi>
    <basicUdiDi>B-10190302017305</basicUdiDi>
    <tradeName>Ion Torrent™ Oncomine™ Dx Express Test Panel</tradeName>
    <deviceName>Ion Torrent™ Oncomine™ Dx Express Test Panel, a part of Ion Torrent™ Oncomine™ Dx Express Test</deviceName>
    <manufacturerName>Life Technologies Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000023929</manufacturerSrn>
    <authorisedRepresentativeName>Life Technologies Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000021890</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>A50871 (A54103, A54103RR)</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-10T21:40:19.485Z</lastUpdated>
  </row>
  <row>
    <udiDi>10190302015134</udiDi>
    <basicUdiDi>B-10190302015134</basicUdiDi>
    <tradeName>Oncomine™ Dx Target DNA Control v2.0 Kit</tradeName>
    <deviceName>Oncomine™ Dx Target DNA Control v2.0 Kit, a part of Oncomine™ Dx Target Test</deviceName>
    <manufacturerName>Life Technologies Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000023929</manufacturerSrn>
    <authorisedRepresentativeName>Life Technologies Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000021890</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>A44913 (A49756)</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-10T21:40:00.287Z</lastUpdated>
  </row>
</eudamedExport>